462
Participants
Start Date
October 31, 2007
Primary Completion Date
September 30, 2013
Study Completion Date
November 30, 2013
ketamine/amitriptyline NP-H cream
Subjects were instructed to apply up to, but not exceeding, 4 g of ketamine/amitriptyline NP-H cream two times per day to each area with pain, numbness, and/or tingling. A measuring device was provided to assist in dispensing the proper amount of the cream.
placebo
Applied topically
CCOP - North Shore University Hospital, Manhasset
CCOP - Hematology-Oncology Associates of Central New York, East Syracuse
CCOP - Upstate Carolina, Spartanburg
CCOP - Greenville, Greenville
CCOP - Grand Rapids, Grand Rapids
CCOP - Marshfield Clinic Research Foundation, Marshfield
CCOP - Metro-Minnesota, Saint Louis Park
CCOP - Evanston, Evanston
CCOP - Central Illinois, Decatur
CCOP - Nevada Cancer Research Foundation, Las Vegas
MBCCOP - Hawaii, Honolulu
CCOP - Columbia River Oncology Program, Portland
CCOP - Virginia Mason Research Center, Seattle
MBCCOP - University of Illinois at Chicago, Chicago
CCOP - Wichita, Wichita
CCOP - Southeast Cancer Control Consortium, Winston-Salem
CCOP - Northwest, Tacoma
National Cancer Institute (NCI)
NIH
Gary Morrow
OTHER